Please enable JavaScript to continue using this application.

Compare $ARTV vs $OCGN | Chartloom

Compare

$ARTV vs $OCGN

Artiva Biotherapeutics Inc · Ocugen Inc

ARTV

Artiva Biotherapeutics Inc

OCGN

Ocugen Inc

Compare $ARTV vs $OCGN

Comparing Artiva Biotherapeutics Inc and Ocugen Inc

ARTVArtiva Biotherapeutics Inc

OCGNOcugen Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

OCGNOcugen Inc

Market cap

$323M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

181.62x

Rev growth (TTM)

0.4%

YTD performance

-30.8%

52W performance

-46.6%

FCF yield

-18.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

OCGN

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

OCGN

Ocugen Inc

Market Cap

ARTV$337M

OCGN$323M

Enterprise Value

ARTV$36M

OCGN$308M

Price

ARTV$6.94

OCGN$0.96

P/E Ratio

ARTVN/A

OCGNN/A

P/S Ratio

ARTV0.00x

OCGN67.77x

EV/Sales

ARTV0.00x

OCGN64.43x

EV/EBITDA

ARTV0.00x

OCGN0.00x

P/B Ratio

ARTV0.96x

OCGN59.59x

P/FCF Ratio

ARTVN/A

OCGNN/A

EV/FCF

ARTV-0.46x

OCGN-5.04x

PEG Ratio

ARTVN/A

OCGNN/A

Forward P/E (NTM)

ARTVN/A

OCGNN/A

Forward P/S (NTM)

ARTVN/A

OCGN181.62x

Revenue (TTM)

ARTV$0

OCGN$5M

Revenue Growth (YoY)

ARTVN/A

OCGN0.4%

Forward Rev Growth

ARTV404.4%

OCGN-47.4%

Gross Margin (TTM)

ARTV0.0%

OCGN0.0%

Operating Margin (TTM)

ARTV0.0%

OCGN0.0%

EBITDA Margin (TTM)

ARTV0.0%

OCGN-1043.0%

Net Margin (TTM)

ARTV0.0%

OCGN-1343.1%

FCF Margin (TTM)

ARTVN/A

OCGN-1278.5%

Net Income (TTM)

ARTV$-42M

OCGN$-64M

FCF (TTM)

ARTV$-77M

OCGN$-61M

EPS (TTM)

ARTV$0.00

OCGN-$0.19

ROE (TTM)

ARTV-6022.0%

OCGN-130671.0%

ROA (TTM)

ARTV-5238.0%

OCGN-8057.0%

ROIC (TTM)

ARTV-6019.0%

OCGN-16519.0%

Cash

ARTV$301M

OCGN$100M

Debt

ARTV$0

OCGN$84M

Net Cash/Debt

ARTV$301M

OCGN$16M

Current Ratio (TTM)

ARTV24.16x

OCGN0.80x

Quick Ratio (TTM)

ARTV23.97x

OCGN0.75x

Debt/Equity (TTM)

ARTV0.00x

OCGN5.03x

Debt/Assets (TTM)

ARTV0.0%

OCGN0.0%

Interest Coverage (TTM)

ARTVN/A

OCGNN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

OCGN0.00x

Beta

ARTV5.80

OCGN1.91

52W Performance

ARTV131.3%

OCGN-46.6%

YTD Performance

ARTV64.1%

OCGN-30.8%

% from 52W High

ARTV-52.2%

OCGN-64.9%

% from 52W Low

ARTV156.1%

OCGN6.2%

Asset Turnover (TTM)

ARTV0.00x

OCGN0.06x

FCF Yield (TTM)

ARTV-22.8%

OCGN-18.9%

Earnings Yield (TTM)

ARTV-12.5%

OCGN-19.8%

Dividend Yield (TTM)

ARTVN/A

OCGNN/A

Rule of 40

ARTV0.0

OCGN-1,278.1

EV/GP/RG

ARTVN/A

OCGNN/A

Ticker research

View ARTV research View OCGN research

Metric	ARTV Artiva Biotherapeutics Inc	OCGN Ocugen Inc
Market & Valuation
Market Cap	$337M	$323M
Enterprise Value	$36M	$308M
Price	$6.94	$0.96
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	67.77x
EV/Sales	0.00x	64.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	59.59x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	181.62x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	0.4%
Forward Rev Growth	404.4%	-47.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1043.0%
Net Margin (TTM)	0.0%	-1343.1%
FCF Margin (TTM)	N/A	-1278.5%
Net Income (TTM)	$-42M	$-64M
FCF (TTM)	$-77M	$-61M
EPS (TTM)	$0.00	-$0.19
ROE (TTM)	-6022.0%	-130671.0%
ROA (TTM)	-5238.0%	-8057.0%
ROIC (TTM)	-6019.0%	-16519.0%
Financial Health
Cash	$301M	$100M
Debt	$0	$84M
Net Cash/Debt	$301M	$16M
Current Ratio (TTM)	24.16x	0.80x
Quick Ratio (TTM)	23.97x	0.75x
Debt/Equity (TTM)	0.00x	5.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.91
52W Performance	131.3%	-46.6%
YTD Performance	64.1%	-30.8%
% from 52W High	-52.2%	-64.9%
% from 52W Low	156.1%	6.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-22.8%	-18.9%
Earnings Yield (TTM)	-12.5%	-19.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,278.1
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View OCGN research

Valuation

P/S Ratio

ARTV

0.00x

OCGN

67.77x

EV/FCF

OCGN

-5.04x

ARTV

-0.46x

Growth & revenue

Revenue Growth TTM

OCGN

0.4%

Forward Revenue Growth

ARTV

404.4%

OCGN

-47.4%

Profitability & performance

Gross Margin

ARTV

0.0%

OCGN

0.0%

ROE

ARTV

-6022.0%

OCGN

-130671.0%

FCF Yield %

OCGN

-18.9%

ARTV

-22.8%

52-Week Performance

ARTV

131.3%

OCGN

-46.6%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

OCGN

Ocugen Inc

Market Cap

ARTV$337M

OCGN$323M

Enterprise Value

ARTV$36M

OCGN$308M

Price

ARTV$6.94

OCGN$0.96

P/E Ratio

ARTVN/A

OCGNN/A

P/S Ratio

ARTV0.00x

OCGN67.77x

EV/Sales

ARTV0.00x

OCGN64.43x

EV/EBITDA

ARTV0.00x

OCGN0.00x

P/B Ratio

ARTV0.96x

OCGN59.59x

P/FCF Ratio

ARTVN/A

OCGNN/A

EV/FCF

ARTV-0.46x

OCGN-5.04x

PEG Ratio

ARTVN/A

OCGNN/A

Forward P/E (NTM)

ARTVN/A

OCGNN/A

Forward P/S (NTM)

ARTVN/A

OCGN181.62x

Revenue (TTM)

ARTV$0

OCGN$5M

Revenue Growth (YoY)

ARTVN/A

OCGN0.4%

Forward Rev Growth

ARTV404.4%

OCGN-47.4%

Gross Margin (TTM)

ARTV0.0%

OCGN0.0%

Operating Margin (TTM)

ARTV0.0%

OCGN0.0%

EBITDA Margin (TTM)

ARTV0.0%

OCGN-1043.0%

Net Margin (TTM)

ARTV0.0%

OCGN-1343.1%

FCF Margin (TTM)

ARTVN/A

OCGN-1278.5%

Net Income (TTM)

ARTV$-42M

OCGN$-64M

FCF (TTM)

ARTV$-77M

OCGN$-61M

EPS (TTM)

ARTV$0.00

OCGN-$0.19

ROE (TTM)

ARTV-6022.0%

OCGN-130671.0%

ROA (TTM)

ARTV-5238.0%

OCGN-8057.0%

ROIC (TTM)

ARTV-6019.0%

OCGN-16519.0%

Cash

ARTV$301M

OCGN$100M

Debt

ARTV$0

OCGN$84M

Net Cash/Debt

ARTV$301M

OCGN$16M

Current Ratio (TTM)

ARTV24.16x

OCGN0.80x

Quick Ratio (TTM)

ARTV23.97x

OCGN0.75x

Debt/Equity (TTM)

ARTV0.00x

OCGN5.03x

Debt/Assets (TTM)

ARTV0.0%

OCGN0.0%

Interest Coverage (TTM)

ARTVN/A

OCGNN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

OCGN0.00x

Beta

ARTV5.80

OCGN1.91

52W Performance

ARTV131.3%

OCGN-46.6%

YTD Performance

ARTV64.1%

OCGN-30.8%

% from 52W High

ARTV-52.2%

OCGN-64.9%

% from 52W Low

ARTV156.1%

OCGN6.2%

Asset Turnover (TTM)

ARTV0.00x

OCGN0.06x

FCF Yield (TTM)

ARTV-22.8%

OCGN-18.9%

Earnings Yield (TTM)

ARTV-12.5%

OCGN-19.8%

Dividend Yield (TTM)

ARTVN/A

OCGNN/A

Rule of 40

ARTV0.0

OCGN-1,278.1

EV/GP/RG

ARTVN/A

OCGNN/A

Ticker research

View ARTV research View OCGN research

Metric	ARTV Artiva Biotherapeutics Inc	OCGN Ocugen Inc
Market & Valuation
Market Cap	$337M	$323M
Enterprise Value	$36M	$308M
Price	$6.94	$0.96
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	67.77x
EV/Sales	0.00x	64.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	59.59x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	181.62x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	0.4%
Forward Rev Growth	404.4%	-47.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1043.0%
Net Margin (TTM)	0.0%	-1343.1%
FCF Margin (TTM)	N/A	-1278.5%
Net Income (TTM)	$-42M	$-64M
FCF (TTM)	$-77M	$-61M
EPS (TTM)	$0.00	-$0.19
ROE (TTM)	-6022.0%	-130671.0%
ROA (TTM)	-5238.0%	-8057.0%
ROIC (TTM)	-6019.0%	-16519.0%
Financial Health
Cash	$301M	$100M
Debt	$0	$84M
Net Cash/Debt	$301M	$16M
Current Ratio (TTM)	24.16x	0.80x
Quick Ratio (TTM)	23.97x	0.75x
Debt/Equity (TTM)	0.00x	5.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.91
52W Performance	131.3%	-46.6%
YTD Performance	64.1%	-30.8%
% from 52W High	-52.2%	-64.9%
% from 52W Low	156.1%	6.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-22.8%	-18.9%
Earnings Yield (TTM)	-12.5%	-19.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,278.1
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View OCGN research